SEC Form 4 · accession 0001349929-15-000008
CANCER GENETICS, INC · CGIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Pappajohn
Director
Period of report
Mar 16, 2015
Accepted (ET)
Mar 18, 2015 · 4:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001349929
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | Mar 16, 2015 | P | 35,000 | $7.4453 | A | 1,499,289 | D | |
| Common Stock, par value $0.0001 per share | Mar 17, 2015 | P | 15,000 | $7.1491 | A | 1,514,289 | D |
Table II — derivative securities
No Table II lines on this filing.